Literature DB >> 12574315

Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole.

Rama Falk, Dana G Wolf, Mervyn Shapiro, Itzhack Polacheck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12574315      PMCID： PMC149729          DOI： 10.1128/JCM.41.2.911.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  6 in total

1.  In vitro antifungal susceptibilities of Trichosporon species.

Authors:  Niki I Paphitou; Luis Ostrosky-Zeichner; Victor L Paetznick; Jose R Rodriguez; Enuo Chen; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

2.  Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units.

Authors:  D G Wolf; R Falk; M Hacham; B Theelen; T Boekhout; G Scorzetti; M Shapiro; C Block; I F Salkin; I Polacheck
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

3.  Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

Authors:  Raoul Herbrecht; David W Denning; Thomas F Patterson; John E Bennett; Reginald E Greene; Jörg-W Oestmann; Winfried V Kern; Kieren A Marr; Patricia Ribaud; Olivier Lortholary; Richard Sylvester; Robert H Rubin; John R Wingard; Paul Stark; Christine Durand; Denis Caillot; Eckhard Thiel; Pranatharthi H Chandrasekar; Michael R Hodges; Haran T Schlamm; Peter F Troke; Ben de Pauw
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

Review 4.  Antifungal drug resistance to azoles and polyenes.

Authors:  Mar Masiá Canuto; Félix Gutiérrez Rodero
Journal:  Lancet Infect Dis       Date:  2002-09       Impact factor: 25.071

5.  In vitro activity of voriconazole against selected fungi.

Authors:  M R McGinnis; L Pasarell; D A Sutton; A W Fothergill; C R Cooper; M G Rinaldi
Journal:  Med Mycol       Date:  1998-08       Impact factor: 4.076

Review 6.  Voriconazole -- better chances for patients with invasive mycoses.

Authors:  Mahmoud A Ghannoum; D M Kuhn
Journal:  Eur J Med Res       Date:  2002-05-31       Impact factor: 2.175
  6 in total
  17 in total

1.  Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis.

Authors:  Carolina Serena; Félix Gilgado; Marçal Mariné; F Javier Pastor; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

Review 2.  Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature.

Authors:  Corrado Girmenia; Livio Pagano; Bruno Martino; Domenico D'Antonio; Rosa Fanci; Giorgina Specchia; Lorella Melillo; Massimo Buelli; Giampaolo Pizzarelli; Mario Venditti; Pietro Martino
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

3.  Supplemental utility of nested PCR for the pathological diagnosis of disseminated trichosporonosis.

Authors:  Makoto Sano; Masahiko Sugitani; Toshiyuki Ishige; Taku Homma; Kentaro Kikuchi; Keishin Sunagawa; Yukari Obana; Yuki Uehara; Kazunari Kumasaka; Kumi Uenogawa; Sumiko Kobayashi; Yoshihiro Hatta; Jin Takeuchi; Norimichi Nemoto
Journal:  Virchows Arch       Date:  2007-09-05       Impact factor: 4.064

4.  Susceptibility patterns and molecular identification of Trichosporon species.

Authors:  Juan L Rodriguez-Tudela; Teresa M Diaz-Guerra; Emilia Mellado; Virginia Cano; Cecilia Tapia; Alexander Perkins; Alicia Gomez-Lopez; Laura Rodero; Manuel Cuenca-Estrella
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

5.  Distribution and antifungal susceptibility of yeasts isolates from intensive care unit patients.

Authors:  Vladimír Hrabovský; Victoria Takáčová; Eva Schréterová; Lydia Pastvová; Zuzana Hrabovská; Katarina Čurová; Leonard Siegfried
Journal:  Folia Microbiol (Praha)       Date:  2017-03-30       Impact factor: 2.099

6.  Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer.

Authors:  Maria N Chitasombat; Diamantis P Kofteridis; Ying Jiang; Jeffrey Tarrand; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  J Infect       Date:  2011-11-11       Impact factor: 6.072

7.  Emerging Trichosporon asahii in elderly patients: epidemiological and molecular analysis by the DiversiLab system.

Authors:  M Treviño; C García-Riestra; P Areses; X García; D Navarro; F J Suárez; I A López-Dequidt; O Zaragoza; M Cuenca-Estrella
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-10       Impact factor: 3.267

8.  Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients.

Authors:  Nanthawan Mekha; Takashi Sugita; Reiko Ikeda; Akemi Nishikawa; Rinrapas Autthateinchai; Natteewan Poonwan; Pathom Sawanpanyalert
Journal:  Mycopathologia       Date:  2010-01       Impact factor: 2.574

9.  Draft genome sequence of CBS 2479, the standard type strain of Trichosporon asahii.

Authors:  Rong Ya Yang; Hai Tao Li; He Zhu; Guang Peng Zhou; Meng Wang; Lei Wang
Journal:  Eukaryot Cell       Date:  2012-11

10.  Trichosporon asahii and Trichosporon inkin Biofilms Produce Antifungal-Tolerant Persister Cells.

Authors:  Rossana de Aguiar Cordeiro; Ana Luiza Ribeiro Aguiar; Bruno Nascimento da Silva; Lívia Maria Galdino Pereira; Fernando Victor Monteiro Portela; Zoilo Pires de Camargo; Reginaldo Gonçalves de Lima-Neto; Débora de Souza Collares Maia Castelo-Branco; Marcos Fábio Gadelha Rocha; José Júlio Costa Sidrim
Journal:  Front Cell Infect Microbiol       Date:  2021-04-22       Impact factor: 5.293
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.